CTAS Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Cintas Corp (CTAS) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has demonstrated solid financial growth in its latest quarter and has potential acquisition news as a positive catalyst, the current technical indicators, insider selling trends, and mixed analyst ratings suggest a cautious approach. Additionally, the lack of strong proprietary trading signals further supports a hold recommendation.
The MACD is positive but contracting, indicating weakening momentum. RSI is neutral at 53.788, and moving averages are converging, showing no clear trend. The stock is trading near its pivot level of 194.418, with resistance at 200.668 and support at 188.169. Short-term price action suggests a potential decline of -0.89% in the next day but a possible 11.57% gain over the next month.
Strong Q2 financial performance with revenue up 9.30% YoY, net income up 10.48% YoY, and EPS up 11.01% YoY.
Acquisition talks with UniFirst, which could drive future growth and market interest.
Stock trading above key moving averages, indicating a potential long-term upward trend.
Insider selling has increased by 129.40% over the last month, signaling potential lack of confidence from insiders.
Mixed analyst ratings with some downgrades and lowered price targets.
Short-term bearish pressure with a regular market change of -2.13% and post-market change of -0.16%.
In Q2 2026, Cintas reported revenue of $2.8 billion, up 9.30% YoY. Net income increased to $493.7 million, up 10.48% YoY. EPS grew by 11.01% to 1.21, and gross margin improved to 50.45%, up 1.22% YoY. These figures highlight strong financial growth and operational efficiency.
Analyst sentiment is mixed. Citi maintains a Sell rating with a price target of $181, while UBS and Wells Fargo highlight strong Q2 performance but have reduced price targets to $235 and $205, respectively. Baird raised its price target to $225 with a Neutral rating, citing accelerating organic growth. Overall, there is no clear consensus among analysts.
